2007
DOI: 10.1016/j.jpba.2006.10.013
|View full text |Cite
|
Sign up to set email alerts
|

LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
45
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 102 publications
(48 citation statements)
references
References 14 publications
(16 reference statements)
1
45
0
Order By: Relevance
“…Bhutani et al studied the LC and LC-MS stress decomposition behavior of ISN by applying different stress conditions [34]. Ustinova et al studied the photo-and oxidation degradation of isoniazid and metronidazole using Fenton's reagent [35].…”
Section: Introductionmentioning
confidence: 99%
“…Bhutani et al studied the LC and LC-MS stress decomposition behavior of ISN by applying different stress conditions [34]. Ustinova et al studied the photo-and oxidation degradation of isoniazid and metronidazole using Fenton's reagent [35].…”
Section: Introductionmentioning
confidence: 99%
“…Isoniazid (isonicotinic hydrazide INH, figure 1) [1,2], first synthesized by Meyer and Mally in 1912 has been used since the 1950s as a first-line antituberculosis drug, characterized by an outstanding minimal inhibitory concentration in the human body [(0.1 to 0.17) mol Á dm À3 ] and having a high specificity toward Mycobacterium tuberculosis. This drug is often administered together with others, as currently recommended by international guidelines when the tuberculosis is still resistant, regardless of the existence of multiple classes of antibiotics.…”
Section: Introductionmentioning
confidence: 99%
“…4 The action mechanism of INH is not totally understood however, the pharmacological activity of the biologically active molecule is related to its chemical structure. 5,6 Several authors have reported on the stability of isoniazid [7][8][9][10] and its compatibility with drugs [11][12][13] and pharmaceutical excipients. 14 Given the above, the development of dosage forms containing isoniazid should be judicious.…”
Section: Introductionmentioning
confidence: 99%